Cargando…
Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties
Macular edema due to neovascular age-related macular degeneration, diabetes or retinal vein occlusion can cause central vision loss. Intravitreal treatment with antibody-based biopharmaceutical compounds designed to neutralize vascular endothelial growth factor (VEGF) has proven to be an efficient s...
Autores principales: | Sivertsen, Magne Sand, Jørstad, Øystein Kalsnes, Grevys, Algirdas, Foss, Stian, Moe, Morten Carstens, Andersen, Jan Terje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794981/ https://www.ncbi.nlm.nih.gov/pubmed/29391560 http://dx.doi.org/10.1038/s41598-018-20525-8 |
Ejemplares similares
-
A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes
por: Lode, Heidrun Elisabeth, et al.
Publicado: (2019) -
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties
por: Jørstad, Øystein Kalsnes, et al.
Publicado: (2023) -
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life
por: Gjølberg, Torleif Tollefsrud, et al.
Publicado: (2022) -
Mask use by patients in the context of COVID‐19 can increase the risk of postinjection endophthalmitis
por: Blom, Kathrine, et al.
Publicado: (2021) -
Cluster of symptomatic silicone oil droplets following intravitreal injections: a 1-year observational study
por: Sivertsen, Magne Sand, et al.
Publicado: (2021)